(MedPage Today) -- The quadrivalent vaccine against human papillomavirus (HPV) is associated with an increased risk of fainting on the day of the shot and of skin infections in the 2 weeks afterward but carries no serious safety concerns, researchers said. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment